Published in N Engl J Med on April 20, 2006
Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med (2006) 11.49
Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med (2006) 9.93
The promise of new rotavirus vaccines. N Engl J Med (2006) 2.58
Synchrony, waves, and spatial hierarchies in the spread of influenza. Science (2006) 10.43
Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med (2005) 8.46
Influenza in tropical regions. PLoS Med (2006) 6.82
Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis (2007) 5.91
Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine (2005) 5.55
The signature features of influenza pandemics--implications for policy. N Engl J Med (2009) 5.37
Influenza and the winter increase in mortality in the United States, 1959-1999. Am J Epidemiol (2004) 5.26
Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. J Infect Dis (2008) 5.18
Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic. J Infect Dis (2005) 4.75
Epidemiological evidence of an early wave of the 1918 influenza pandemic in New York City. Proc Natl Acad Sci U S A (2005) 4.29
Transmissibility and mortality impact of epidemic and pandemic influenza, with emphasis on the unusually deadly 1951 epidemic. Vaccine (2006) 4.28
Seasonality of influenza in Brazil: a traveling wave from the Amazon to the subtropics. Am J Epidemiol (2007) 4.06
Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog (2006) 3.82
Mortality due to influenza in the United States--an annualized regression approach using multiple-cause mortality data. Am J Epidemiol (2005) 3.58
Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog (2008) 3.25
Reassessing Google Flu Trends data for detection of seasonal and pandemic influenza: a comparative epidemiological study at three geographic scales. PLoS Comput Biol (2013) 2.85
Preliminary Estimates of Mortality and Years of Life Lost Associated with the 2009 A/H1N1 Pandemic in the US and Comparison with Past Influenza Seasons. PLoS Curr (2010) 2.77
Evolutionary dynamics of GII.4 noroviruses over a 34-year period. J Virol (2009) 2.74
Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science (2009) 2.67
Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog (2007) 2.52
Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio (2011) 2.48
Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico. PLoS Med (2011) 2.41
Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences. J Infect Dis (2011) 2.33
A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J Infect Dis (2002) 2.33
Cross-protection between successive waves of the 1918-1919 influenza pandemic: epidemiological evidence from US Army camps and from Britain. J Infect Dis (2008) 2.29
Molecular epidemiology of A/H3N2 and A/H1N1 influenza virus during a single epidemic season in the United States. PLoS Pathog (2008) 2.09
Global mortality estimates for the 2009 Influenza Pandemic from the GLaMOR project: a modeling study. PLoS Med (2013) 2.07
Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A (2010) 1.96
Mortality burden of the A/H1N1 pandemic in Mexico: a comparison of deaths and years of life lost to seasonal influenza. Clin Infect Dis (2011) 1.87
Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One (2013) 1.84
Mortality patterns associated with the 1918 influenza pandemic in Mexico: evidence for a spring herald wave and lack of preexisting immunity in older populations. J Infect Dis (2010) 1.78
Vaccinating to protect a vulnerable subpopulation. PLoS Med (2007) 1.76
The protective effects of neighborhood collective efficacy on British children growing up in deprivation: a developmental analysis. Dev Psychol (2009) 1.74
Prioritization of influenza pandemic vaccination to minimize years of life lost. J Infect Dis (2008) 1.69
Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis (2010) 1.62
Hospitalizations and deaths from diarrhea and rotavirus among children <5 years of age in the United States, 1993-2003. J Infect Dis (2007) 1.51
Air travel and the spread of influenza: important caveats. PLoS Med (2006) 1.49
Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project. Eur J Pediatr (2010) 1.44
Description of a rule-based system for the i2b2 challenge in natural language processing for clinical data. J Am Med Inform Assoc (2009) 1.40
Evolution, safety, and highly pathogenic influenza viruses. Science (2012) 1.36
Spatial and temporal characteristics of the 2009 A/H1N1 influenza pandemic in Peru. PLoS One (2011) 1.35
Mercury concentrations in Bicknell's thrush and other insectivorous passerines in Montane forests of northeastern North America. Ecotoxicology (2005) 1.35
Patterns and interpretation of mercury exposure in freshwater avian communities in northeastern north America. Ecotoxicology (2005) 1.32
Influenza-related mortality in the Italian elderly: no decline associated with increasing vaccination coverage. Vaccine (2006) 1.31
Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J (2010) 1.30
Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One (2012) 1.29
Comparative evolution of GII.3 and GII.4 norovirus over a 31-year period. J Virol (2011) 1.28
The reproduction number of seasonal influenza epidemics in Brazil, 1996-2006. Proc Biol Sci (2010) 1.28
Epidemiological characterization of a fourth wave of pandemic A/H1N1 influenza in Mexico, winter 2011-2012: age shift and severity. Arch Med Res (2012) 1.25
Influenza vaccination and mortality benefits: new insights, new opportunities. Vaccine (2009) 1.24
Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis (2012) 1.24
1951 influenza epidemic, England and Wales, Canada, and the United States. Emerg Infect Dis (2006) 1.23
Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J Virol (2010) 1.23
The influence of climatic conditions on the transmission dynamics of the 2009 A/H1N1 influenza pandemic in Chile. BMC Infect Dis (2012) 1.22
Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969-2001. Emerg Infect Dis (2007) 1.22
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology (2009) 1.21
Impact of the 2009 influenza pandemic on pneumococcal pneumonia hospitalizations in the United States. J Infect Dis (2011) 1.19
Were equatorial regions less affected by the 2009 influenza pandemic? The Brazilian experience. PLoS One (2012) 1.17
Age-dependent susceptibility to manganese-induced neurological dysfunction. Toxicol Sci (2009) 1.16
Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA. Mol Ther Nucleic Acids (2012) 1.16
Transmission potential of influenza A/H7N9, February to May 2013, China. BMC Med (2013) 1.14
Gradual changes in the age distribution of excess deaths in the years following the 1918 influenza pandemic in Copenhagen: using epidemiological evidence to detect antigenic drift. Vaccine (2011) 1.13
Estimating deaths due to influenza and respiratory syncytial virus. JAMA (2003) 1.11
Beyond the nasoseptal flap: outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction. Laryngoscope (2014) 1.11
The need for interdisciplinary studies of historic pandemics. Vaccine (2011) 1.09
Global mortality of 2009 pandemic influenza A H1N1. Lancet Infect Dis (2012) 1.07
Rotavirus serotype G9 strains belonging to VP7 gene phylogenetic sequence lineage 1 may be more suitable for serotype G9 vaccine candidates than those belonging to lineage 2 or 3. J Virol (2004) 1.06
Trends in intussusception hospitalizations among US infants, 1993-2004: implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics (2008) 1.06
Recrudescent wave of pandemic A/H1N1 influenza in Mexico, Winter 2011-2012: Age shift and severity. PLoS Curr (2012) 1.05
US flu mortality estimates are based on solid science. BMJ (2006) 1.02
Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus? PLoS Med (2010) 1.02
The 1918-19 influenza pandemic in Boyacá, Colombia. Emerg Infect Dis (2012) 1.02
Epidemiology and evolution of rotaviruses and noroviruses from an archival WHO Global Study in Children (1976-79) with implications for vaccine design. PLoS One (2013) 1.00
Mortality and morbidity burden associated with A/H1N1pdm influenza virus. PLoS Curr (2009) 0.99
Mercury bioaccumulation and trophic transfer in the terrestrial food web of a montane forest. Ecotoxicology (2009) 0.99
Major depressive disorder among older African Americans, Caribbean blacks, and non-Hispanic whites: secondary analysis of the National Survey of American Life. Depress Anxiety (2013) 0.99
Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico. PLoS One (2012) 0.98
Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res (2006) 0.97
Commentary: benefits of influenza vaccine in US elderly--new studies raise questions. Int J Epidemiol (2005) 0.96
Influenza vaccination in elderly people. Lancet (2005) 0.96
Homotypic and heterotypic serum isotype-specific antibody responses to rotavirus nonstructural protein 4 and viral protein (VP) 4, VP6, and VP7 in infants who received selected live oral rotavirus vaccines. J Infect Dis (2004) 0.95
Mercury levels in mink (Mustela vison) and river otter (Lontra canadensis) from northeastern North America. Ecotoxicology (2005) 0.95
Severe acute respiratory syndrome: developing a research response. J Infect Dis (2004) 0.94
Complementary and alternative medicine for mental disorders among African Americans, black Caribbeans, and whites. Psychiatr Serv (2009) 0.94
Mercury in the northern crayfish, Orconectes virilis (Hagen), in New England, USA. Ecotoxicology (2005) 0.93
Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico. BMC Infect Dis (2012) 0.93
Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children. J Infect Dis (2006) 0.92
Reappraisal of the association of intussusception with the licensed live rotavirus vaccine challenges initial conclusions. J Infect Dis (2003) 0.91
Inorganic nutrients and contaminants in subsistence species of Alaska: linking wildlife and human health. Int J Circumpolar Health (2009) 0.91
Mortality burden of the 2009-10 influenza pandemic in the United States: improving the timeliness of influenza severity estimates using inpatient mortality records. Influenza Other Respir Viruses (2013) 0.91
Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis (2013) 0.90
The art of modeling the mortality impact of winter-seasonal pathogens. J Infect Dis (2012) 0.90
Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: the dynamics of PCV13 vaccine uptake. Vaccine (2013) 0.89
A hexavalent human rotavirus-bovine rotavirus (UK) reassortant vaccine designed for use in developing countries and delivered in a schedule with the potential to eliminate the risk of intussusception. J Infect Dis (2005) 0.89
The perils of using annual all-cause mortality data to estimate pandemic influenza burden. Vaccine (2011) 0.89
Influenza-related mortality trends in Japanese and American seniors: evidence for the indirect mortality benefits of vaccinating schoolchildren. PLoS One (2011) 0.88
The integration of mental and behavioral health into disaster preparedness, response, and recovery. Disaster Med Public Health Prep (2012) 0.88